Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies

IJMS, Free Full-Text

Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort

Full article: The use of blood biomarkers in precision medicine for the primary prevention of atherosclerotic cardiovascular disease: a review

Atherosclerosis Nature Reviews Disease Primers

Frontiers Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies

Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: A review of the evidence - Pompilio Faggiano, Nicolò Dasseni, Nicola Gaibazzi, Andrea Rossi, Michael Henein, Gregg Pressman, 2019

4 Case Studies, Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Inflammation and cardiovascular disease: From mechanisms to therapeutics - ScienceDirect

The Role of Lipids and Lipoproteins in Atherosclerosis - Endotext - NCBI Bookshelf

Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort

International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia

Advances in mechanical biomarkers - Eroles - 2023 - Journal of Molecular Recognition - Wiley Online Library